-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 WBOw8PupDEhxhtNgaN4v41M/txM/qbGOL5oyav6XmWQ7FWxL4y+8r5XRHwHmDMhc
 fgTkVhyuaXMOQP7QUOQekQ==

<SEC-DOCUMENT>0000950123-09-018121.txt : 20090831
<SEC-HEADER>0000950123-09-018121.hdr.sgml : 20090831
<ACCEPTANCE-DATETIME>20090626183216
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950123-09-018121
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20090626

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ONCOGENEX PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1522 217TH PLACE S.E.
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		4254879500

	MAIL ADDRESS:	
		STREET 1:		1522 217TH PLACE S.E.
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE>Correspondence</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><IMG src="c87398p8739801.gif" alt="(DORSEY &#038; WHITNEY LLP LOGO)">
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>RANDAL R. JONES<BR>
(206)&nbsp;903-8814<BR>
FAX (206)&nbsp;903-8820<BR>
JONES.RANDAL@DORSEY.COM</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">June&nbsp;26, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Division of Corporation Finance<BR>
U.S. Securities and Exchange Commission<BR>
100 F Street, N.E.<BR>
Washington, D.C. 20549-7010

</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%"><B>Re: OncoGenex Pharmaceuticals &#151; Registration Statement on </B><B>Form S-3</B><B> (File No.&nbsp;333-160251)
filed on June&nbsp;26, 2009</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%">Dear Sir or Madam,
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">In connection with the Registration Statement on Form S-3 (file no. 333-160251) filed on June
26, 2009 by OncoGenex Pharmaceuticals, Inc., we are furnishing the correspondence attached as
Exhibit&nbsp;A required under National Instrument 71-101.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ Randal R. Jones
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Randal R. Jones&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">&nbsp;
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">&nbsp;
</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><IMG src="c87398p8739802.gif" alt="(CONTACT GRAPHIC)">
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXHIBIT A</B>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>NOTICE OF FILING PURSUANT TO NATIONAL INSTRUMENT 71-101</B><BR>
<B><I>The Multijurisdictional Disclosure System</I></B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>TO:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>British Columbia Securities Commission</B></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>AND TO:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>The United States Securities and Exchange Commission</B></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>RE:</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>OncoGenex Pharmaceuticals, Inc. (the &#147;Company&#148;)</B></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">The Company has today filed a preliminary MJDS prospectus dated June&nbsp;26, 2009, pursuant to National
Instrument 71-101, <I>The Multijurisdictional Disclosure System </I>(&#147;<B>NI 71-101</B>&#148;), and designates the
British Columbia as the principal jurisdiction in Canada.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">DATED June&nbsp;26, 2009.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>ONCOGENEX PHARMACEUTICALS, INC.</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="38%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="58%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Scott Cormack
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Scott Cormack
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">President and Chief Executive Officer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>c87398p8739801.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c87398p8739801.gif
M1TE&.#EAY0`I`'```"'Y!`$``/``+`````#E`"D`A____P```/[^_OW]_?S\
M_/CX^._O[^GIZ>CHZ.?GY^OKZ_'Q\??W]_O[^^/CX]S<W-K:VN#@X/GY^?3T
M].WM[>;FYMW=W=;6UM/3T_KZ^M+2TLC(R,W-S=O;V^KJZO;V]O#P\//S\[Z^
MOKN[N\S,S-#0T+>WM^[N[LK*RM'1T;FYN:.CHZNKJ\[.SNSL[,#`P*&AH:BH
MJ+:VMJJJJKR\O.'AX>7EY;2TM(V-C9.3D\'!P<7%Q9:6EI"0D(N+BZ"@H-75
MU9J:FG=W=\/#P\3$Q,;&QMG9V:RLK**BHKJZNLO+R]?7UW]_?X^/C[&QL=[>
MWHF)B7-S<YZ>GG%Q<6UM;:6EI6AH:`0$!`("`@X.#C`P,&IJ:GY^?A45%2PL
M+`8&!@,#`P<'!ST]/5M;6P$!`1X>'G)R<D%!0104%%)24@D)"6MK:Q@8&(>'
MAW5U=8J*BK^_OV%A87IZ>J^OKVQL;&!@8",C(PT-#1,3$Q(2$@H*"EA86`4%
M!1$1$3HZ.@\/#TE)245%19*2DCDY.38V-IF9F86%A8.#@UY>7G!P<)N;FV5E
M95]?7YV=G2DI*0@("-_?WX&!@2LK*R8F)M34U)24E&]O;S\_/S4U-<+"PDA(
M2(B(B*:FIF=G9["PL+*RLJ>GIVYN;E5555!04%%146)B8H"`@&1D9"HJ*DI*
M2D!`0*ZNK@L+"QP<'"$A(1\?'UU=75965@P,#(Z.CKBXN*2DI&-C8X*"@A86
M%A`0$.+BXL_/SR@H*"0D)&EI:69F9C@X.$M+2]C8V!D9&4)"0E-34_+R\AL;
M&QH:&JFIJ:VMK9B8F!<7%Y65E7Q\?%E965I:6B(B(CX^/G9V=GM[>WAX>!T=
M'71T=/7U]4Y.3B\O+\?'QX:&AB<G)X2$A,G)R;.SLTQ,3)>7ES(R,BTM+24E
M)30T-$-#0T1$1$='1[V]O>3DY)R<G)&1D9^?G[6UM0``````````````````
M``````````````````````````````````````````````C_``$('$BPH,&#
M"!,J7,BPH<.'$"-*G$A1(KR*&#-JW,BQH\>/`R^"'$FRI,F3)$66/,&R94N4
M,&/*-*D2X@D+."T\;)F3!,X3,X,*'=JP)L,3))):8.GP)M.!-TF,&$$"*-&K
M6&<:18ATQ(RJ$V]:2.J3H(41A;YF7<L6Y-:")[Q^M9JQZXP1.@6>F+%ITXBV
M@`-/?#N01"&_="LBS0O``M]")`9:*"1D4V2)2*5JILK99V*%CM.*GC%:](C/
M!#>K[DR5X=G5JE%#A<VZ+,*Q#6V'Y$K9<L>S,QB3V"2D$-T9OW[-D/@K@//G
MT)^/^_57H9`^T;-#CU:]H!#MX,=U_R]H013XZ'V$H#XQ[CST/N@N$QSA7'W"
M$\W[R`?PU@)QWQ\-MYQ>A8@B!&,S""'*)K)Q%<US?40H(7;1B<)809NX=]Y^
M`K6G873C#83.A]"-\YD%)$(88B'2<2@0"1X&4`A!6YVPR2]"N,C1"+_,J)>"
MOS!62'(^-G3"@P&<]M.2(VR"9`#1N'BD<^+E9*65+-9GD(?BU485"3-XB(Y!
M,SC7AU^TS6"><P,61B%U=\4IUR\4B@+7B,\5*5"&SXF2V%9J%F?2D$5:D)Q]
M`)P@Q"^BZ'C0E`%<:)"-ST5S(H6.8NC<F`7AV>9MV/4A*9^_,,2B?N1A%\U"
M)#RXR4%\.O]G86-K.O=J04;AAV.F&Y&0'&,W4C?0D+_<>M2#HC(4JQ"I!M"'
M0V4&P"E!'H8XJ9F?93F.I`<M91`)S_':&+>%/1G-+T^.HZ-1ON+8($<VBM(=
MCPL6EER01GHH;H=4-MO'NP1%.ZV(FRYEL%,&KVEBL\Z.@\XX#D<<\2\Z6D"A
MM!`_''%\1C:7W2\-&L5CL0!OM(DH;8[,K$"&_FHDDN0:Y/&J9H5:LD`";_G>
MA#P_]^E`,URL81\_`T""T."5ZE`A%Q.M$+N'WHR1HLH--+*Q[>+;$)+[`L!E
M8A8[*W7.G:;HK)[D+2J**(RN[;8H2"9;LYG1C%/WW1!;JQ!]SNG_32-<A\;,
M$0F+`LMH=VH6VQ2R@@_[G+$LAPKMIG!Y&$U?F&-^L=+=W@SIS^`Z>UJB0#VE
M5^-02;X0H#BB_1%R;;:,*-7"ONR<N+%&(VG823;TG;0&X>DZRW$/?[33"ZV)
M=MC/@O;@\.3!O/JDB_I%T@B"ZA6LD(Q"_RBRD;W4TG!/H@H7DM%\1=;Z9/T>
MP,K4]IU0JX\;%*MR[).%?;@%'5U?_DG!7IU<8[/I3>H_78N(8=IT@B'E"&C)
M@=RQS-2':$2C@A7,#CIBEB6S.8M;U0)-C';W)!+9B3P>[-U"3D"ADA%F,IN`
MS&^F(ASB%"(O<2&21&KEGG/Y;2";0)I[_]1UD._H;H7M&9AD1"'$[/2!<V:)
MD8;0\4."G&!$2CP(802"ED*,KBY@85F39,BRWB30('*9@1K7J$:\2"U1:62C
M'.^R-]3IY8O=BN,<U<*5/<JQ-3O!8T*V>,>TA+$NP,$+5,8H2,$X\I&X,I)4
MJ/)&*[)D+$JA"W`@4TE(>O(JA#0()CWSQDN>:)*Z^:0J(1E*KEBIDCPAB[=6
M24M/MA*1"'-*+7>IREOR\I?`I(@O=WF6J7#(,7Q\T50461@U"F>9U3GD(5,3
MG&[E99;>P@E4A*/,999./MJ$XS(O(Q^DB')WDHJ+-PTRS%HV22I>+`QD)M,=
M+\(S+X89RPT%8O](0!J&90R:%&2,(TH?D8:?.@&3U:K30)8M$"P6>*#1&.H7
M&O*S.FK\%NA`!QEX?J:=M)P*$*VRST0%%`!%4B@`Z$@ZG!UDGR>%2YP00M`8
M-L9'(E4F@>;#F,D0-*>.$>A-AI?39O:OGI("Z2J+VAH;$:2DG)S,91J83)1^
MA9F)*D0\'T6<A'P%F6.)ICT-PU`]59-EP9F15+3W);IXI:3]VVC_;JC/CP9S
M;X@+GUGS(IH#61%,!+6J,><C0:A`)C@5NTL`_5E1M##T4V=MS'+45QW_K!.(
M1>-BB%0J3Z]@=3=W14A1H0HLD@(%KHSQBDN[E5G)-L:F`IU1`P-;U+6U9C5@
MX!Q06LHJVIAQ]D6@JZ)25>F5FV24B\;92YL(ZA^2_J6!EYEG.(%[FTTL)8:R
M.<R>VL19VS84:#T=D*$J:]V<X%:T=/56/G]BM-8*9+B?G$P;"X(6-=(EC(!4
M+DL!4%_[SF9^:M1,M\@)S@+?,36,,>>+ILK&\:32+&O<IWR=V1A>P3>T-L%P
M8"ZLX0[SDL,>#G$OX4'B$IOXQ"A.L8I7S.(6N_C%,(ZQC&=,XQK;N,8!`0`[
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>c87398p8739802.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c87398p8739802.gif
M1TE&.#EA<0(O`'```"'Y!`$``-0`+`````!Q`B\`A____P```/#P\+*RLJ^O
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MS,'!P;>WM_;V]GIZ>L+"PHF)B8N+BX2$A(R,C)24E)>7E\#`P(B(B)B8F(*"
M@HV-C8>'A^CHZ(:&AF)B8I&1D86%A6UM;9F9F8.#@^WM[=#0T.'AX7M[>\3$
MQ*.CHY.3DX^/CVYN;LC(R(J*BIZ>GG=W=X"`@)R<G)V=G5M;6WQ\?)"0D#L[
M.SHZ.C<W-SX^/MK:VIN;FY*2DIJ:FK6UM965E8Z.CJ:FIDE)24A(2$1$1*"@
MH(&!@9^?GW5U=7!P<')R<CDY.:2DI):6ECT]/6]O;WU]?79V=GAX>'-S<W%Q
M<4)"0D-#0T9&1DM+2W]_?V9F9F-C8W1T=&QL;'EY>7Y^?C0T-#8V-C\_/VMK
M:T%!06AH:&IJ:E965EU=75]?7U=75UQ<7&EI:6%A84U-355555145&5E95!0
M4$]/3TQ,3%Y>7E-34TI*2D='1U%1461D9%E965A86$!`0&!@8!,3$PX.#A$1
M$6=G9Q@8&!\?'T5%1104%%)24A86%B$A(5I:6BDI*3,S,TY.3@``````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````C_``$('$BPH,&#
M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*[$AMI,F3*%.J7,FRI<N7
M,&/*;%ERILV;.'/JW,FSI\^?)($*'4JTJ-&C2)/*K*E4YPP=$2+H,!@UPHR!
M,ZI.Q0K5JL"G59\(%#OPR56#3R*0+3ACK8BR8PF*.#L70%:I4:^*>/N5;]:N
M;]L2W$IP!E^":['BU7%8X=Z^<.L"D&P8@-N!D@<N/JLYKV*H.CB#]2JPJ]JX
MF!M/CG"&<.DS$0X+3MU01%7/"KN*AIH8K.NR41NGC5`8],'1<J,FMDVZM-2'
M=ZNJ1AM\\'/KH0TR7UX=>'/KWZ.Z_]Z.^#0`IDUQBJCS!"J7LS.XQ([P7B#]
M]O2_MA:A@XO`]>T]01876ZUW'!<BU,>6?Y/5\A^#"@(0E7U3/:4#*#J8)6$M
M9^FP%7T9,F87@J^A=89!=7#VVA/\19C0$R<"H$,=SDE('`!GQ/@<B0!@*)"+
MZV5('V?RM9>B?02F%2..C,VH%R@"9B@0;%\=6187`N8X4(XM\O4$AP/5P>!"
M.DACIC2*_%90</UM&1N66S)V75EGB/"$@G>VZ*9M2\;)7XSQL=C:@P(JJ$.=
M5#94IB*,*G(C0C#:R>.A(B1JXY\+LLACH'>>Q9J>!5':Z8]R`HIEI04B""=Z
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MO5[3VMYK3A,$&\4%`;LOME`9'-]TP8H%VU0C&P;;7*:6>R+,ZV+_5?1:ZK8]
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MS^N8!:):Y8A'>#J1`&=8M2<H`DV,@EMA_T9D+\V(93UOV>!D$)25<1D->&F1
MCW9TURS-R(<]F!M0S6;`O.:Y!'A#0UNX)F2Z6KTEA-:!E`Z;13OY3*4J'-/,
M^A@H1_MM*UEFF^%8K$6ME4&*AT7"T9PB9S#8K"4J)XJB=I841K?LC#AE_-$1
MZX?&$1V$<S,8%P"Q-!^J7*YRESO(J"9(M*M(R9)I@TV[%-2[*A7$7RG,'H18
MATH<J<9`H9)&YC*CD$`=K8'VB^.ZI%(T+P%*7HSSU"1+B15+U>=67?0B2]2&
M/(;-45ED41N<@!>J$BY06:!`2`1`<<9:K.58UR0BK&3DHW(A!&UI\Z:R^A?*
MA7V+:O.#D/<:5/\A"XHPF%/:RIW<M#+^`91)!TWE/W%$%O(MT5/.(@X74L3-
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MQIJ7&S5Z,*B\"VO.8A!FP6>7N56U>A[R"X%(E%2EHL0P`II.@`HCFL2=<BP"
M$A!U%:)=B1T'*W+9KEU41-[J]B6[O:$==J/[%?3"AR*B8<M"P6M1S+C43BQ"
MRW7':]^R[!>]Z9UO6T0DEZSFU*7J/0XO$;*7["(F.P\V'%=>]Y373;>^8]GO
M@!M3X5<2V"$+3DA;\&NX#__GPRBS2WO(.[8"`Z[$%K[NB`6TF[,TU[DXSK&.
M=\SC'L/DQCX.LI"'3.0B"QG(1DZRDI?,Y";;!,E.CK*4ITSE*C<$RCJQ4X*Q
M,I<M0R3!6J9NE^D+U.`9C#+A(^]<0KP0];)8_X-L-C.;UXRR-,<YP>0=8E_&
M_-TR^SE\<894H.E[YO!9E,Z"+AC34N-EM/"2SM@239?K4NC*^%F$:^XE15B$
M9S++%ROY[4NES_OI2Q=FT?]!=4(>`]]35ZV'`\%R2M#&/?THUK42TI]3:^6:
M_,3+G4N$&_9VS85FL?%QESWC_JIGO@CH6F!BVM]W>EE)`)25MJPYK'Q(-JW]
MY>@JUYG>_L326`O&"&T&QLI=F0G,)YC;H$ZZGKQ_+6X)]E(^].$+K?6M;"XP
MVY2ZYJ$J27;M)=[':K#A-D(.%A4LRBC:$I2KN^H@)N+`R-_']MB^C*U1@QSL
M+%:*4,%'=.N?SAM^5O^*++95>/%_+_&&AREXQQ%>P]?T9SPNVEZ?[M+F=6/;
M9@/UFPIEC1*TV0S8*A<G8`U'/PZV<UNWLW>LL!E4%%FIX]SLW3,;5YMB]X]8
MZK2V2W=F+8=R\$-ZY)PMU]F_75?3CV4A&"F'2EI@0^0Z+3;ZQ42S+#QVTW'L
MS%A@QI4@4\H3(7Q3N=_/IR*UU[+N?FLTU45@SH,FJ$_;ROM:^`8L=]_(8YFD
MY2\E61H&95)ID:X;*G$ZHGTN#FWNKN>4R+DKNB>H[U.!%]%/HO=7'EWI1--L
MI0XCE<V%-30^QYQLA+DO8'$/;.;!U^._K"O0"FQ))`(6V$J98J]1R&WE,=O_
M8=*].HV.<:?]4\[<-0[UPR^$IN(79J^R+GO.D*XU@-W26_BV_54?G?QIH7%S
M1T=P1U0,`3.'\EB/@BB'H3IY9#6?-ROJ-S2.1X`;Q"."!4R,HW_`I$0=%SI]
M(H#481X:%R%F1R[0M!/<4VNOL5CB1#\3]2CDHW%J`3%05VS[5!`*IS]=<RO/
M@75]AV^),C!GPT-J55&9<UT:HBYS0C*9=$$SXVPY4D*+<SY3J#NB]%@9PRL=
MHC\*M$D`I3;M$C_?IAW"EB.$T7MKMU&:L5?3]A7TL2QUTF*X(Q9-"&>7-(5M
MF&V<83[+XGAC)4\\6'_^@2AK.(-4B(9;@C[.]GDW_](V_N$QSP$:@#,F:B<L
M/C@5,V=3/N=NU*,:$?([F/<UAF9)"H1"HK$DK/<>NV<21N=F@Z5T9S8ILD,X
M;Q0BI4%.06<0OX=-94-4"*)`"<4:GJ=N#28^"G>"_7$7Y*4OJ+@@+E5'<*4B
M`K@?7',Y:+@_<@1%=;(7M!0ICWA88=6-(19)''4CM*8YLM$GP>&-#'8PMO,>
MG@$\PL(S^%,_JS$KY`@?&#(CVN)-@<B++,)J"?$K)V*0GN)9.6@_Y\88>]$N
MP`(SX"@S^*&*8R*`.,0KXV,B)0>/;3%S'VA,X<=1%`,;O=4Q!N1`-74MK3@2
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M:+YR2=JB/IF!);WE<8V#+&G7)[U2@5%3A1.%&`CRBXM#A+5B%J.460/I$.##
M<+3_A9HZ<Q@;]"G?&2KOL9QYV1E/@7UF`4^YT4*I>5MV\ABL)WTK5!BN]SZL
M1B#'N!H'07DN57G[N42R4CKGMGG.HH\#X4^D8AA>5WM3TD+$YBE@HH/<:2K<
MF7.&\QZ%ET8+\9)FD2Q@`R/+*9JCB3[P<5A=:1DS%#F&!%*#T3'CQQ=V4A9Z
M5"E9J1E0Q1>N$9-/@1C$ISG9MHF]Q%5^@89SPB>AI":A%FJOE!B+)J56LQLZ
MNB[;DSUKT5T,R3V5<C;N=Q!-Y1J1TQQ":J93R),T%RVRD6U:"I8L9"EABEEV
M8:8X.D/C`54ALZ6N>4E72J.!>EN6(J4YJF*IEJ5P6"2)__$;95JCFC&@4V@X
M9\-AOQ$YMR1$B)&*;#H;"+<5*FIEHCJJI`H=<EJJ,1&JJ+JJK#JJW=>J.*&J
ML#JKM%JKMAH4MYJKNKJKO,H1LMJKP!JLPBJJOSJLQGJLR'IDR;JLS-JL45:L
MSAJMTCJM.@&MU'JMV)JM)V&MVMJMWOJM%,&MX#JNY%JNL6:NZ)JNZBH1XKJN
M[KIDT:@1\0H2KXH1\\H0]PI4KY93X"5Y#I&O"M&N[SJPSA5]%3,C$^5O'3<P
MN$85U2,F$%I!LB%W_U%"SC88T>8M,\>PT$%Q8E('Q+)?[@,*'XN%.$*R"4LL
MXU2RZ^FQ$^5P#J&-F$%Q";MNS_\'=@(AL`2[LT%CLC]R(K+I-A\7)HK@F_\:
MM+/(CXJ`3W:!)F#W)9C!*&/B;&Z3(!FJ+$'T$(I@%N`F47VBC;(9,3.@"'.Q
MM4+K+<IR,@)!,%L[7N9X28RR@"GB-J>!LUQ0"XK`&3K+LWR;%",G11IK;.<4
M3A'@(`5CN%+C']4Y&>%T!HK@'UW5MK5PF`4QN3]"N(C;9M)0/1.J+%,)M&X4
M%503FVE#(W=;%=1C%IL[4?@H2F0[MMD$<574(Q?C((5[KGV;NU'FLSBB0TYC
M)V0K(<=0"Q,5`'VT<%?K76<0`-4#"@'P0N'$N,0;O;5P#&*B",=@ASN7)C)R
M#(];!\?_P+0+,;GW*3&S6Z$`4`OHPAK'\$*9:QGA=+>@H3!CFR&/H:F%(0W/
M4&SZ&QB_^X0]0F[#.U'9F[.Z>\!,5KA0U;84A[KA)`);>Y_G,J8$0;+95@<.
MXD,-9B?F1+I6(PT.XF\;K`.V*YN^50LOE"8;3+$B]KA5X4\DO*;<*[[G\A8N
M?#;^Y()?H0BJ5+@4_*#O(R@T0L*WX2/D5+\2#"9[B\!,S!-I08E_54#WQ1;X
M>W9X,<7;I1J5,1U=YB%>#!]<W!!/;!S7`\7>U5^^0<9L]L26!6+:D6%X01;^
M^TH&W,1V?,>V2@UZO,=\W,=^_,>`',B"/,B$7,B&?,B(G,B*'+S(C-S(COS(
6D!S)DCS)E%S)EGS)F)S)FGS)`0$`.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
